Cutting edge: DNAX accessory molecule 1–deficient CD8+ T cells display immunological synapse defects that impair antitumor immunity

KM Ramsbottom, ED Hawkins, R Shimoni… - The Journal of …, 2014 - journals.aai.org
KM Ramsbottom, ED Hawkins, R Shimoni, M McGrath, CJ Chan, SM Russell, MJ Smyth
The Journal of Immunology, 2014journals.aai.org
Abstract DNAX accessory molecule 1 (DNAM-1) is expressed on all CD8+ T cells and
promotes their activation and effector function. DNAM-1 interacts with LFA-1, a critical
molecule for immunological synapse formation between T cells and APCs, and for cytotoxic
killing of target cells. Mice that lack DNAM-1 display abnormal T cell responses and
antitumor activity; however, the mechanism involved is unclear. In this article, we show that
DNAM-1 deficiency results in reduced proliferation of CD8+ T cells after Ag presentation and …
Abstract
DNAX accessory molecule 1 (DNAM-1) is expressed on all CD8+ T cells and promotes their activation and effector function. DNAM-1 interacts with LFA-1, a critical molecule for immunological synapse formation between T cells and APCs, and for cytotoxic killing of target cells. Mice that lack DNAM-1 display abnormal T cell responses and antitumor activity; however, the mechanism involved is unclear. In this article, we show that DNAM-1 deficiency results in reduced proliferation of CD8+ T cells after Ag presentation and impaired cytotoxic activity. We also demonstrate that DNAM-1–deficient T cells show reduced conjugations with tumor cells and decreased recruitment of both LFA-1 and lipid rafts to the immunological synapse, which correlates with reduced tumor cell killing in vitro. This synapse defect may explain why DNAM-1–deficient mice cannot clear tumors in vivo, and highlights the importance of DNAM-1 and the immunological synapse in T cell–mediated antitumor immunity.
journals.aai.org